Skip to content

Clinical trials

Sudden Infant Death trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Sudden Infant Death Country / region: United States Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20071
20083
20095
20101
20112
20123
20131
20145
20152
20172
20184
20191
20202
20213
20226
20231
20241
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Recruiting7
Terminated7
Active, not recruiting5
Not yet recruiting2
Withdrawn2
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
REGENXBIO Inc.6
Shire6
Denali Therapeutics Inc.4
University of Virginia3
Johns Hopkins University2
Paul Szabolcs2
University of Minnesota2
Aldagen1
Arkansas Children's Hospital Research Institute1
ArmaGen, Inc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Sudden Infant Death51
Mucopolysaccharidosis II27
Lysosomal Storage Diseases9
Mucopolysaccharidosis I8
Mucopolysaccharidoses7
Mucopolysaccharidosis VI7
Leukodystrophy, Globoid Cell6
Mucopolysaccharidosis III5
alpha-Mannosidosis5
Adrenoleukodystrophy4

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.